m+Medelevator.RU
← Поиск публикаций
Cureus · 2026

Characterizing Heterogeneity in Behavioral Phenotypes Among Oral Nicotine Pouch Users in Saudi Arabia: A Latent Class Analysis.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Gosadi Abdullah M, Dighriri Naif A, Hurubi Yahya A, Safhi Abdulkarim H, Mujarribi Ali M, Mashyakhi Fahad M, Hodani Ahmed M, Ageeli Abdullah A, Tayran Albara E, Somily Abdulmjeed H, Darbashi Nawaf A, Alghamadi Ayah H, Madkhali Hassan A, Sabei Fahad Y

Аннотация

Background The rapid proliferation of oral nicotine pouches has polarized public health discourse, framing these products as either reduced-risk alternatives or catalysts for novel addiction pathways. Conventional research frequently obscures the functional heterogeneity underlying these outcomes. This investigation employs a person-centered framework to identify distinct behavioral phenotypes among adult users in Saudi Arabia and evaluate their clinical implications. Methods A cross-sectional analytical study assessed adult pouch consumers (N=310) residing in the Jazan province. Latent class analysis-derived user typologies are mathematically grounded in behavioral indicators, encompassing consumption frequency, nicotine strength preference, poly-product utilization, and functional motives. Results The analysis revealed three divergent trajectories. The "Harm Reduction-Motivated De-escalator" phenotype (n=65, 21.0%) exhibited low-intensity consumption driven by tapering intent. Conversely, the "Stable, Affect-Regulating Dual-User" (n=117, 37.7%) displayed a maintenance pattern characterized by homeostatic mood management. Most critically, the "Escalating, High-Intensity Poly-Product User" (n=128, 41.3%) emerged as a high-risk cohort defined by a distinct preference for supratherapeutic nicotine strengths (≥10 mg) alongside the highest rate of simultaneous poly-product use (n=67, 52.3%). Consequently, this escalating group demonstrated significantly elevated odds of experiencing localized gum irritation (aOR = 3.25) compared to the de-escalator baseline. Conclusions Consumers do not appear to constitute a monolithic population; clinical risk appears to be shaped primarily by user behaviors and functional motivations rather than inherent product properties alone. Although a minority utilizes these products for rational harm reduction, the concerning prevalence of escalating poly-users highlights a potential toxicity trap driven by high-intensity stacking behaviors. Public health strategies might benefit from transitioning toward targeted behavioral profiling and customized therapeutic interventions.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты